Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serious diseases
16 employees · est. 2000 · Bozeman, United States
Spero Therapeutics
Clinical-stage biotech company focused on rare diseases and diseases with high unmet need
44 employees · est. 2013 · Cambridge, United States
Microbion Corporation is the older company (2000 vs 2013).
Side-by-Side Comparison
| Metric | Microbion Corporation | Spero Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2013 |
| Headquarters | ||
| Headquarters | Bozeman, United States | Cambridge, United States |
| Employees | ||
| Employees | 16 | 44 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series Unknown | IPO |
| Total Funding | ||
| Total Funding | Not tracked yet | $374.60M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 12 |
| Services | ||
| Services | Not tracked yet | Development of Oral Carbapenem Antibiotics, Drug Pipeline for Rare and MDR Infections, Clinical Trial Execution, Partnership Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Complicated Urinary Tract Infections, Patients with Pyelonephritis, Healthcare Providers, Pharmaceutical Collaborators |
| Taxonomy | ||
| Taxonomy | Pharmaceuticals, Therapeutics, Drug Development, Clinical-stage Biotechnology, Microbial Biofilm Prevention, Chronic Lung Diseases, Orthopedic Infections, Rare Disease Treatments, Antibiotic Resistance, Inhaled Drug Delivery, Topical Drug Development, Medical Device Coatings, Biofilm Prevention Technologies, Agricultural Biofilm Prevention, Industrial Biofilm Prevention | Biopharmaceutical, Clinical-stage, Biotech Company, Bacterial Infections, Multi-drug Resistant, Rare Diseases, Oral Antimicrobial Agent, IV-administered Agent, Antibiotic, NTM Pulmonary Disease, Complicated Urinary Tract Infections, Business Development, Partnership Directed Programs, Drug Development, Commercialization |
| Website | ||
| Website | microbioncorp.com | sperotherapeutics.com |
About Microbion Corporation
Microbion Corporation is a clinical-stage pharmaceutical company focusing on developing therapeutic compounds for rare and serious diseases. The company's lead drug candidate, pravibismane, has received substantial support, totaling over $21 million in grants from the Cystic Fibrosis Foundation, NIH...
About Spero Therapeutics
Spero Therapeutics, founded in 2013 and headquartered in the United States, is a multi-asset, clinical-stage biotech company specializing in treatments for multidrug-resistant bacterial infections and rare diseases. With a strong focus on addressing antibiotic resistance, the company is carving out...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Microbion Corporation and Spero Therapeutics — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Microbion Corporation and Spero Therapeutics — by email.
Frequently Asked Questions
Compare Microbion Corporation with someone else
Start typing a company name or domain.